Document NNG1N8mEmxM362p860500rpxR

AMENDMENT NO.1 TO AGREEMENT FOR THE CONDUCT AND FUNDING OF A RESEARCH PROGRAM ON BENZENE HEALTH RISK FROM OCCUPATIONAL EXPOSURES The above agreement by and between the undersigned companies (hereafter the" Benzene Health Research Program" or "Research Group"), to establish and fund a research program on the Iymphohematopoietic health risks from occupational exposure to benzene, is amended as follows: 1. Section 9. f. (Payment Schedule) is amended as follows: August 2003 Remaining not-to-exceed balance for $1.5 million/share August 2004 0% August 2005 0% In all other respects, the terms and conditions of the above agreement shall remain in full force and effect. If the foregoing is acceptable, please sign below and return one copy of this amendment to Contract Administrator, American Petroleum Institute, 1220 L Street, NW, Washington, DC 20005 (202-682-8093). SHELL-MCCLURG-065713 DRAFT RATIFICATION AND EXECUTION OF AMENDMENT NO.1 TO THE AGREEMENT FOR THE CONDUCT AND FUNDING OF A RESEARCH PROGRAM ON BENZENE HEALTH RISK FROM OCCUPATIONAL EXPOSURES ACCEPTED FOR: Company Name Signed Name Typed Title Date Telephone:_ _ _ _ _ _ _ _ __ Fax:- - - - - - - - - - - - Email:_ _ _ _ _ _ _ _ _ _ __ Contact person (if different than signer above:) Name and Title Telephone:_ _ _ _ _ _ _ _ __ Fax:- - - - - - - - - - - - Email:_ _ _ _ _ _ _ _ _ __ SHELL-MCCLURG-06S714 DRAFT RATIFICATION AND EXECUTION OF AMENDMENT NO.1 TO THE AGREEMENT FOR THE CONDUCT AND FUNDING OF A RESEARCH PROGRAM ON BENZENE HEALTH RISK FROM OCCUPATIONAL EXPOSURES ACCEPTED FOR: AMERICAN PETROLEUM INSTITUTE Red Cavaney President Date Brenda S. Hargett Chief Financial Officer Date SHELL-MCCLURG-065715 Shanghai Health Study Benzene Health Research Consortium Contract Review Contract Name: _Sponsor/ConocoPhillips_ _ _ _ _ _ _ _ _ _ _ _ _ _ __ Effective Date: Renewal Date: -------- Terms: compensation amount, payment schedule, termination option, audit, work product ownership: Deliverables - Timeline: Issues: -Part 2IResponsibility for Full Costs: -Review "responsibility for full costs" as some sponsors may not agree to cover costs for "add-on" test procedures to the original protocols. -Where ever the term "2/3 of all votes cast" appears, is this referring to the 11 votes or the # of sponsors? And sometimes the "2/3" refers to votes cast, and other times to "vote among all members". -Part 9: Estimated budget sum needs changed. Review the "maximum" cost per share being $1.5 million and also the "payment schedule". Recommendations: -The above issues can be discussed at the Nov. mtg of the Oversight Committee. Reviewer: OC Review: W. Broddle- - - - - -Review Date: Oct. 30, 2003_ Changes: Approval Date: SHELL-MCCLURG-065716